GILEAD SCIENCES INC's ticker is and the CUSIP is 375558AP8. A total of 1 filers reported holding GILEAD SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,918,000 | -1.9% | 711,000 | +7.4% | 0.10% | -2.1% |
| Q4 2015 | $2,976,000 | -30.0% | 662,000 | -32.4% | 0.10% | -22.4% |
| Q3 2015 | $4,252,000 | -6.4% | 980,000 | +11.4% | 0.12% | +8.7% |
| Q2 2015 | $4,542,000 | -12.1% | 880,000 | -26.6% | 0.12% | -11.5% |
| Q1 2015 | $5,166,000 | -52.6% | 1,199,000 | -54.4% | 0.13% | -50.6% |
| Q4 2014 | $10,888,000 | -11.4% | 2,630,000 | 0.0% | 0.26% | -15.4% |
| Q3 2014 | $12,287,000 | -24.7% | 2,630,000 | -41.2% | 0.31% | -21.3% |
| Q2 2014 | $16,311,000 | -3.3% | 4,473,000 | -17.5% | 0.40% | -4.4% |
| Q1 2014 | $16,870,000 | -12.2% | 5,419,000 | -7.6% | 0.41% | -17.4% |
| Q4 2013 | $19,208,000 | -14.0% | 5,867,000 | -27.2% | 0.50% | -17.5% |
| Q3 2013 | $22,322,000 | +22.2% | 8,059,000 | 0.0% | 0.61% | +15.4% |
| Q2 2013 | $18,267,000 | -36.2% | 8,059,000 | -38.9% | 0.52% | -40.7% |
| Q1 2013 | $28,634,000 | -6.6% | 13,184,000 | -27.6% | 0.89% | -11.1% |
| Q4 2012 | $30,673,000 | – | 18,208,000 | – | 1.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INCOME RESEARCH & MANAGEMENT | 9,376,000 | $40,393,000 | 6.90% |
| MACKAY SHIELDS LLC | 12,148,000 | $52,358,000 | 2.77% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,500,000 | $6,465,000 | 2.53% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 6,200,000 | $26,710,000 | 2.53% |
| SSI INVESTMENT MANAGEMENT LLC | 4,620,000 | $19,905,000 | 1.88% |
| CNO Financial Group, Inc. | 500,000 | $2,154,000 | 0.91% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 13,789,000 | $59,376,000 | 0.86% |
| Man Investments (CH) AG | 400,000 | $1,724,000 | 0.83% |
| Lombard Odier Asset Management (Europe) Ltd | 2,380,000 | $10,242,000 | 0.80% |
| CQS Cayman LP | 3,750,000 | $16,252,000 | 0.76% |